JinSystem and Jeju National University Industry-Academic Cooperation... "Development of Rapid Diagnostic System"

[Asia Economy Reporter Hyunseok Yoo] Rapid on-site molecular diagnostic platform company JinSystem is seeking industry-academic cooperation with Jeju National University Animal Hospital for companion animal infectious disease diagnosis.

JinSystem announced on the 26th that it signed an industry-academic cooperation agreement with Jeju National University Animal Hospital to develop a rapid diagnostic system for companion animal infectious diseases.

Through this cooperation, JinSystem plans to develop and commercialize diagnostic kits that can quickly and accurately diagnose major infectious diseases in companion animals, mainly dogs and cats, at animal hospitals.

Yoon Young-min, director of Jeju National University Animal Hospital, stated, “Through industry-academic cooperation, it is expected that the innovative diagnostic platform technology of JinSystem and the clinical testing environment of the animal hospital can be effectively utilized to enable the development and commercialization of a rapid diagnostic system.”

So far, JinSystem, as a rapid on-site molecular diagnostic platform company, has focused on reducing the existing molecular diagnostic test time from 2 hours to 30 minutes and simplifying the testing process from 6 steps to 3 steps, significantly improving convenience. Through its platform technology, it is expected that infectious disease diagnostic tests for animals will be possible quickly and easily not only at specialized testing centers but also on-site at animal hospitals in the future.

In addition, JinSystem donated a total of 200 million KRW worth of in-kind goods, including a rapid molecular diagnostic platform and gene amplification reagents, to Jeju National University. Through this, they plan to lay the foundation for expanding the base of diagnostic technology.

Seo Yoo-jin, CEO of JinSystem, said, “We will lead the diversification of the animal diagnostic portfolio through industry-academic cooperation and donations,” adding, “Our goal is to supply rapid diagnostic systems for animal infectious diseases to the global market beyond Korea and to faithfully serve as a platform contributing to the growth of the bio industry.”

Meanwhile, JinSystem plans to go public within the first half of the year after demand forecasting and subscription next month. The lead underwriter is Samsung Securities.

This content was produced with the assistance of AI translation services.